VRPX

Companies
NASDAQ
Virpax Pharmaceuticals Inc.
Health Care
Price Chart
Overview

About VRPX

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Market Cap
$1.6M
Volume
161.3K
Avg. Volume
162.1K
P/E Ratio
-0.7438889
Dividend Yield
0.00%
Employees
7.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.54
Low Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for VRPX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, VRPX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$1.6M
Volume161.3K
P/E Ratio-0.74
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
November 16, 2023
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how VRPX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025